96 related articles for article (PubMed ID: 2364144)
1. [The effect of a 3-hydroxypyridine-class antioxidant on disorders of the microcirculatory system in experimental dyslipoproteinemia and its alimentary correction].
Klimenko ED; Kobozeva LP; Michunskaia AB; Zolotov NN; Khabarina IIu; Pozdniakov OM
Biull Eksp Biol Med; 1990 Mar; 109(3):234-7. PubMed ID: 2364144
[TBL] [Abstract][Full Text] [Related]
2. [Function of the microcirculatory system during the long-term regression of the early stages of atherogenesis].
Klimenko ED; Kobozeva LP; Michunskaia AB; Khabarina IIu
Biull Eksp Biol Med; 1988 Mar; 105(3):365-8. PubMed ID: 3349181
[TBL] [Abstract][Full Text] [Related]
3. [Disorders in the microcirculatory system in experimental dyslipoproteinemia].
Pozdniakov OM; Klimenko ED
Vestn Akad Med Nauk SSSR; 1988; (2):35-40. PubMed ID: 3376524
[No Abstract] [Full Text] [Related]
4. [Synthetic antioxidant correction for disorders of the regulatory and microcirculatory systems in the early stages of experimental atherosclerosis].
Pozdniakov OM; Klimenko ED; Kobozeva LP; Michunskaia AB; Smirnov LD
Biull Eksp Biol Med; 1993 Mar; 115(3):242-4. PubMed ID: 8054604
[TBL] [Abstract][Full Text] [Related]
5. [Interrelation of the changes in the blood rheological properties and the microcirculatory disorders in the early and late stages of experimental hyperlipoproteinemia].
Khugaeva VK; Klimenko ED; Aleksandrov PN; Leskova GF; Reutov MI
Biull Eksp Biol Med; 1985 Jul; 100(7):15-9. PubMed ID: 4016234
[TBL] [Abstract][Full Text] [Related]
6. [The role of dyslipoproteinemia in the genesis of chronic hepatitis].
Klimenko ED; Pozdniakov OM
Biull Eksp Biol Med; 1992 Oct; 114(10):437-9. PubMed ID: 1288717
[TBL] [Abstract][Full Text] [Related]
7. [The correction of the pathological changes in the neuroendocrine system in hyperlipoproteinogenic microangiopathy].
Pozdniakov OM; Kobozeva LP; Michunskaia AB; Khabarina IIu; Klimenko ED
Patol Fiziol Eksp Ter; 1997; (2):9-11. PubMed ID: 9235544
[TBL] [Abstract][Full Text] [Related]
8. [The use of enterosorbent SKN in hyperlipoproteinemias (clinical and experimental research)].
Sledzevskaia IK; Bratus' VV; Babov KD; Bul'da VI; Strelko VV; Voronkov GS; Evstratova IN; Sergienko OV; Taranenko VM; Isaechkina IM
Ter Arkh; 1992; 64(8):15-7. PubMed ID: 1440387
[No Abstract] [Full Text] [Related]
9. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet.
Ramesh E; Elanchezhian R; Sakthivel M; Jayakumar T; Senthil Kumar RS; Geraldine P; Thomas PA
Fundam Clin Pharmacol; 2008 Jun; 22(3):275-84. PubMed ID: 18485145
[TBL] [Abstract][Full Text] [Related]
10. [Blood aggregation and the system of microcirculation in experimental atherosclerosis, its spontaneous regression and hemosorption].
Sergienko VI; Novikov II; Vlasov VB; Efimov VS; Semenova TI
Biull Eksp Biol Med; 1986 May; 101(5):553-6. PubMed ID: 3708136
[TBL] [Abstract][Full Text] [Related]
11. [Hyperlipidemia and decrease of lipid tolerance as factors of atherogenesis].
Ambroskina VV; Kriachok TA; Larionov OP; Talaieva TV; Bratus' VV
Fiziol Zh (1994); 2007; 53(6):19-28. PubMed ID: 18309627
[TBL] [Abstract][Full Text] [Related]
12. [The hypolipidemic and antiatherosclerotic properties of the ammonium salt of glycyrrhetic acid and of 18-dehydroglycyrrhetic acid].
Zakirov UB; Abdullaev AKh
Eksp Klin Farmakol; 1996; 59(5):53-5. PubMed ID: 9026213
[TBL] [Abstract][Full Text] [Related]
13. [Changes in the microcirculatory bed and blood microcirculation in the mesentery of the small intestine of rabbits with experimental hypercholesterolemia].
Tutatchikov VP
Arkh Anat Gistol Embriol; 1983 Dec; 85(12):51-7. PubMed ID: 6667132
[TBL] [Abstract][Full Text] [Related]
14. [Influence of cell therapy and alimentary correction on the condition of microcirculatory system in experimental dyslipidemia].
Kobozeva LP; Michunskaia AB; Kulikova OS; Bersenev AV; Klimenko ED; Onishchenko NA; Pozdniakov OM
Patol Fiziol Eksp Ter; 2005; (4):28-9. PubMed ID: 16408665
[TBL] [Abstract][Full Text] [Related]
15. [A specialized product with antioxidant action in the treatment of lipid disorders in experimental hyperlipoproteinemia].
Ivanova IL; Ian'kova VI; Knyshova VV; Kozlovskaia EP
Vopr Pitan; 2000; 69(1-2):13-5. PubMed ID: 10942997
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the water-soluble antioxidant hydroxypyridine-6 on the intensity of lipid peroxidation in eye tissues in experimental ophthalmic herpes].
Kasavina BS; Maĭchuk IuF; Dalgat LD; Romashchenko AD
Biull Eksp Biol Med; 1982 Jul; 94(7):27-8. PubMed ID: 7126819
[TBL] [Abstract][Full Text] [Related]
17. [Experimental peroxide atherosclerosis in rabbits].
Voskresenskiĭ ON; Bobyrev VN
Vopr Pitan; 1981; (3):42-5. PubMed ID: 7269447
[TBL] [Abstract][Full Text] [Related]
18. [Role of the patho-autokinetic element in the pathogenesis of disturbances of myocardial lipid composition induced by experimental atherogenic dyslipoproteinemia].
Kalinkin MN
Patol Fiziol Eksp Ter; 1991; (5):14-7. PubMed ID: 1806882
[TBL] [Abstract][Full Text] [Related]
19. [Structural and functional status of the adrenergic innervation of the terminal portions of the vascular bed in experimental hypercholesterolemia].
Lebedeva LN; Kobozeva LP
Biull Eksp Biol Med; 1982 Dec; 94(12):96-100. PubMed ID: 7150777
[TBL] [Abstract][Full Text] [Related]
20. [The use of alisat for correction of level of lipids and their peroxidation products in blood of patients with atherosclerosis].
Mikhin VP
Biull Eksp Biol Med; 1998 Sep; 126(9):345-9. PubMed ID: 9805629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
